News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
A random telephone survey of Harvard and Radcliffe undergraduates yesterday revealed that a majority of students are skeptical of the value of the U.S. swine flu vaccination program.
Forty-nine per cent of responding students indicated that they do not plan to submit to vaccination, while 35 per cent said they would line up at UHS whether or not swine flu reappeared this fall.
All of the 37 students polled had heard of swine flu.
Most undergraduates who said they plan to ask for the vaccine said they felt the risk involved was minimal and saw no reason to gamble on contracting swine flu. The skeptics pointed to the unlikelihood of an epidemic and the unknown risks of the vaccine.
One Business School student, contacted accidentally, said he would take the vaccine "if they market it hard." A Harvard undergraduate said that he "knew very little about it and was willing to trust the federal government."
Representing the opposing viewpoint, a Harvard junior said, "I haven't seen anyone getting sick and dropping off, and I've got a lot of other business to attend to.
Want to keep up with breaking news? Subscribe to our email newsletter.